HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laser in situ keratomileusis and diode thermal keratoplasty for correction of hyperopia from +5.00 to +10.00 diopters.

AbstractPURPOSE:
To evaluate the effects and safety of laser in situ keratomileusis (LASIK) and diode thermal keratoplasty (DTK) for correction of moderate to high hyperopia (+5.00 to +10.00 D).
METHODS:
This prospective study included 30 eyes of 15 patients who had LASIK-DTK bioptics. The median age of the patients was 50.5 years. LASIK was performed using a Nidek EC-5000 excimer laser system and DTK by a Prolaser DTK laser, 2 months after LASIK. Follow-up ranged from 9 to 12 months (mean, 10.5 mo).
RESULTS:
The mean preoperative spherical equivalent refraction was +8.25 +/- 0.25 D and mean postoperative was +1.00 +/- 0.50 D. The preoperative best spectacle-corrected visual acuity (BSCVA) was < or = 20/40 in 10 eyes and > or = 20/25 in 20 eyes. Postoperatively, BSCVA was < or = 20/40 in 8 eyes and > or = 20/25 in 22 eyes. No significant intra- or postoperative complications occurred.
CONCLUSION:
LASIK-DTK bioptics for correction of moderate to high hyperopia (+5.00 to +10.00 D) was safe and effective. In this method, two different ablative and non-ablative laser systems were used to compensate for regression, which is the most important concern in the correction of hyperopia.
AuthorsAhmad Salamat Rad, Mahmood Jabbarvand, Mohammad Mehdi Farahvash, Arash Kheradvar
JournalJournal of refractive surgery (Thorofare, N.J. : 1995) (J Refract Surg) 2002 May-Jun Vol. 18 Issue 3 Suppl Pg. S318-20 ISSN: 1081-597X [Print] United States
PMID12046872 (Publication Type: Journal Article)
Topics
  • Adult
  • Cornea (surgery)
  • Female
  • Humans
  • Hyperopia (surgery)
  • Keratomileusis, Laser In Situ (methods)
  • Laser Coagulation (methods)
  • Male
  • Middle Aged
  • Prospective Studies
  • Refraction, Ocular
  • Safety
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: